Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.
about
Bipolar disorder and alcohol use disorder: a reviewPsychosocial interventions for people with both severe mental illness and substance misusePsychosocial interventions for people with both severe mental illness and substance misuseSubstance abuse and schizophrenia: pharmacotherapeutic interventionA roadmap to key pharmacologic principles in using antipsychoticsThe impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trialPharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.A systematic review of the international published literature relating to quality of institutional care for people with longer term mental health problemsFree-running rhythms of cocaine self-administration in rats held under constant lighting conditions.Intrinsic motivation as a mediator of relationships between symptoms and functioning among individuals with schizophrenia spectrum disorders in a diverse urban community.Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.Integrating mental health and addictions services to improve client outcomes.Advisor-Teller Money Manager (ATM) therapy for substance use disorders.Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine.Cigarette smoking and mortality risk in people with schizophrenia.Dual recovery among people with serious mental illnesses and substance problems: a qualitative analysisA cluster randomized Hybrid Type III trial testing an implementation support strategy to facilitate the use of an evidence-based practice in VA homeless programs.Physical Health and Dual Diagnosis.Beyond the limitations of best practices: how logic analysis helped reinterpret dual diagnosis guidelines.The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disordersThe catatonic dilemma expandedExcess mortality in persons with severe mental disorder in Sweden: a cohort study of 12 103 individuals with and without contact with psychiatric services.Adapting Motivational Interventions for Comorbid Schizophrenia and Alcohol Use Disorders.Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia.Implementing Residential Integrated Treatment for Co-occurring DisordersCigarette Smoking and Health Characteristics in Individuals With Serious Mental Illness Enrolled in a Behavioral Weight Loss Trial.Professionals' perception on the management of patients with dual disorders.Comorbid psychiatric and substance abuse disorders: recent treatment research.A Hybrid III stepped wedge cluster randomized trial testing an implementation strategy to facilitate the use of an evidence-based practice in VA Homeless Primary Care Treatment Programs.The efficacy of assertive community treatment to treat substance use.Helping homeless individuals with co-occurring disorders: the four components.Directions for future patient-centered and comparative effectiveness research for people with serious mental illness in a learning mental health care systemOpiate dependence in schizophrenia: case presentation and literature review.Treatment of substance use disorders in schizophrenia.Jail-to-community treatment continuum for adults with co-occurring substance use and mental disorders: study protocol for a pilot randomized controlled trial.Naltrexone efficacy in treating alcohol-use disorder in individuals with comorbid psychosis: a systematic reviewIntegrating services for patients with mental and substance use disorders: What matters?Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community behavioral health organizations.Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: a preliminary investigation.Cigarette smoking, nicotine dependence, and motivation for smoking cessation in psychiatric inpatients.
P2860
Q22252584-E5C408DF-4444-40D6-A4E5-04EA2FF0589EQ24197576-042EF383-7539-452A-B5CC-3AB2D14F2DEAQ24242339-F078E8B9-A070-44F1-A127-01329A315776Q24621711-8718DDCC-A9A9-4E08-A81E-B3BE597DE8C0Q24678461-BE5D93A6-80B4-4A36-87D2-940404888877Q30301208-FBED07BD-E638-42E5-ACC2-F8B752788C41Q30366778-547F0949-EC82-47EF-BAF0-D906C5330ECDQ33500672-B451D2CE-5FDC-49BB-8F1C-1D2873DEB7E2Q34104417-F08BA38B-721C-4846-A683-877ECBA179DFQ34160441-DBA12F84-1507-43D0-AE80-B7CBDF562A9BQ34347478-CCC0794E-A6B4-4AB5-A105-C876CD7204EBQ34373311-4E96F72A-9F7D-4FD5-8D0F-951D1CD9E020Q34718546-B063F2C5-12C5-4F33-B131-677B1A463DD0Q34994773-83E6B3E6-36C6-4B75-90E8-A21176C95125Q35065406-1A900E6C-2FD5-4D7B-B6D5-731527F1B954Q35079480-5A013FD7-E667-41B5-8FB3-FF58B32D7735Q35663322-D8681C3C-7861-482C-9E96-39876F479B99Q36009165-D9AE501E-DD73-4F11-B068-FB6D5D2A9656Q36542180-893E6B5F-DF9C-44B5-ACB3-B4FBE2D68570Q36570221-323BACEE-4479-40B4-A81B-C3EEAB6A2BDEQ36588430-ED761CE3-4B68-49B6-AB03-26079FE1201EQ36957061-9306758D-0C41-45E1-8CDC-100E7EC33DF2Q37010033-E72B92C7-2573-4E99-8707-434F0C24BC45Q37079797-94B8AB17-E772-44FA-A903-39065E3AB2C3Q37102870-A54DEA57-97CE-449A-BCCB-8CB78E350241Q37190653-7FDBE8B1-C57A-4AE4-8D84-659299A4C544Q37279671-03F16266-45A5-44F4-8298-8F49BD4D7808Q37337682-E96F2B05-33B2-47E3-80E6-A479B781019BQ37736729-CFFD77C2-59C7-46FA-82B8-01F431143226Q37870700-EFB880CC-2371-4A98-90DD-16F8781D1089Q38024372-50252741-D143-4EB3-B7DF-27DACF53BE0CQ38184528-8A19ACCE-0788-4FBA-8ED9-E6349C76E30FQ38267760-42000A75-2F83-4AC2-8FC6-A8A6D453077EQ38813826-1F1D9F93-3249-4A58-A5EB-C34A92C4AA07Q40492690-F774DB2E-CBC8-4183-A4F8-D26BDF1CD573Q41664978-616D07FB-1B7B-4BB3-8F94-068B1773C0B3Q41891550-B190841C-3E8C-4D2F-BD19-3F1BAB3DBB18Q42659528-E2887A1F-74E4-403C-A85B-703138B1CD5EQ44697721-AE17BE0F-219F-498D-85C2-E4BCB20F8264Q46142680-2E669D81-AC5F-4DD8-B6B9-B4A7DBE3B0EC
P2860
Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Improving the care of individu ...... rs: consensus recommendations.
@ast
Improving the care of individu ...... rs: consensus recommendations.
@en
type
label
Improving the care of individu ...... rs: consensus recommendations.
@ast
Improving the care of individu ...... rs: consensus recommendations.
@en
prefLabel
Improving the care of individu ...... rs: consensus recommendations.
@ast
Improving the care of individu ...... rs: consensus recommendations.
@en
P2093
P2860
P1476
Improving the care of individu ...... rs: consensus recommendations.
@en
P2093
Alan I Green
David Smelson
Douglas M Ziedonis
Ivan Montoya
Joseph Parks
Renata J Henry
Richard N Rosenthal
Roger D Weiss
Steven L Batki
P2860
P304
P356
10.1097/00131746-200509000-00005
P577
2005-09-01T00:00:00Z